全文获取类型
收费全文 | 6764篇 |
免费 | 474篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 150篇 |
妇产科学 | 105篇 |
基础医学 | 951篇 |
口腔科学 | 164篇 |
临床医学 | 644篇 |
内科学 | 1681篇 |
皮肤病学 | 86篇 |
神经病学 | 658篇 |
特种医学 | 261篇 |
外科学 | 1026篇 |
综合类 | 59篇 |
一般理论 | 5篇 |
预防医学 | 366篇 |
眼科学 | 131篇 |
药学 | 334篇 |
中国医学 | 8篇 |
肿瘤学 | 551篇 |
出版年
2023年 | 60篇 |
2022年 | 102篇 |
2021年 | 187篇 |
2020年 | 134篇 |
2019年 | 168篇 |
2018年 | 199篇 |
2017年 | 149篇 |
2016年 | 163篇 |
2015年 | 200篇 |
2014年 | 266篇 |
2013年 | 334篇 |
2012年 | 531篇 |
2011年 | 511篇 |
2010年 | 329篇 |
2009年 | 271篇 |
2008年 | 482篇 |
2007年 | 453篇 |
2006年 | 403篇 |
2005年 | 391篇 |
2004年 | 319篇 |
2003年 | 315篇 |
2002年 | 272篇 |
2001年 | 61篇 |
2000年 | 53篇 |
1999年 | 65篇 |
1998年 | 53篇 |
1997年 | 41篇 |
1996年 | 46篇 |
1995年 | 49篇 |
1994年 | 31篇 |
1993年 | 45篇 |
1992年 | 34篇 |
1991年 | 35篇 |
1990年 | 33篇 |
1989年 | 34篇 |
1988年 | 45篇 |
1987年 | 35篇 |
1986年 | 26篇 |
1985年 | 22篇 |
1984年 | 28篇 |
1983年 | 27篇 |
1982年 | 28篇 |
1981年 | 26篇 |
1980年 | 13篇 |
1979年 | 21篇 |
1978年 | 16篇 |
1975年 | 12篇 |
1974年 | 17篇 |
1973年 | 13篇 |
1972年 | 13篇 |
排序方式: 共有7262条查询结果,搜索用时 15 毫秒
101.
102.
Andre R. Dur?es Milena A. O. Dur?es Luis C. L. Correia Roque Aras 《Arquivos brasileiros de cardiologia》2013,101(5):466-471
Heart valve prosthesis unquestionably improve quality of life and survival of
patients with severe valvular heart disease, but the need for antithrombotic therapy
to prevent thromboembolic complications is a major challenge to clinicians and their
patients. Of the articles analyzed, most were retrospective series of cases or
historical cohorts obtained from the database. The few published randomized trials
showed no statistical power to assess the primary outcome of death or thromboembolic
event. In this article, we decided to perform a systematic literature review, in an
attempt to answer the following question: what is the best antithrombotic strategy in
the first three months after bioprosthetic heart valve implantation (mitral and
aortic)?After two reviewers applying the extraction criteria, we found 1968 references,
selecting 31 references (excluding papers truncated, which combined bioprosthesis
with mechanical prosthesis, or without follow-up).Based on this literature review, there was a low level of evidence for any
antithrombotic therapeutic strategy evaluated. It´s therefore interesting to use
aspirin 75 to 100 mg / day as antithrombotic strategy after bioprosthesis replacement
in the aortic position, regardless of etiology, for patients without other risk
factors such as atrial fibrillation or previous thromboembolic event. In the mitral
position, the risk of embolism, although low, is more relevant than in the aortic
position, according to published series and retrospective cohorts comprised mostly of
elderly non-rheumatic patients.The current evidence is limited to have a consistent and safe level of evidence
regarding the best therapeutic strategy. Based on these studies, 75 to 100 mg/day of
aspirin is interesting as antithrombotic strategy after implantation of aortic
bioprosthesis, regardless of etiology, for patients with no other risk factors such
as atrial fibrillation or previous thromboembolic event. As for mitral bioprosthesis,
the risk of embolism, although low, is more relevant than in the aortic position,
according to published series and retrospective cohorts - usually elderly non
rheumatic patients. 相似文献
103.
Background: Quantification of left ventricular torsion may provide new indices of systolic and diastolic function. We sought to characterize the effect of acute manipulation of load on cardiac torsion, plecotropy in human subjects. Methods: Simultaneous Millar LV pressure, micromanometry, and echocardiograms were performed on 18 patients (10 male, mean age 66 years) with normal systolic function. Loading was altered sequentially by the administration of glyceryl trinitrate (GTN) and saline fluid loading. Echocardiographic speckle tracking imaging was used to quantify LV torsion and event timing was recorded relative to mitral valve opening (MVO). Results: GTN administration decreased preload (LV end diastolic pressure: 15.7 vs 8.4 mmHg, P < 0.001), and afterload (wall stress: 140 vs 84 ×103dyn/cm2, P < 0.02). Administration of fluid increased preload (LVEDP 11.3 vs 18.1 mmHg, P < 0.001) and increased wall stress, but to a lesser extent (102 vs 117 ×103dyn/cm2, P < 0.003). GTN administration augmented peak torsion (8.4 vs 11.0 deg, P < 0.05), increased systolic torsion velocity (46.6 vs 65.3deg/sec, P < 0.01) and resulted in earlier onset of untwisting (–105 vs –127ms, P < 0.05). Fluid loading decreased the proportion of untwisting prior to MVO (39.0 vs 31.0%, P < 0.05), untwisting acceleration (–750 vs –592deg/sec/sec, P < 0.05) and delayed the timing of peak untwisting (–37.0 vs 9.1ms, P < 0.01), but did not affect systolic torsion parameters. Conclusions: Left ventricular torsion parameters are sensitive to acute changes in load and therefore need to be interpreted in the context of current loading conditions. (ECHOCARDIOGRAPHY 2010;27:407‐414) 相似文献
104.
Birrer A Jusufi F Bernimoulin M Tichelli A Gratwohl A Nissen-Druey C Dirnhofer S Meyer-Monard S Stern M 《European journal of haematology》2008,81(4):267-272
In the absence of a cytogenetic abnormality or overt dysplasia, chronic myelomonocytic leukemia (CMML) may be difficult to be distinguished from reactive monocytosis. We have previously described a typical growth pattern in CMML patients, i.e., 'pseudonormal' colonies resembling granulocytic colonies but consisting entirely of monocytic cells when stained. To study the utility of the colony forming unit cell assay (CFU-C) as a diagnostic tool in patients with monocytosis, we analyzed a cohort of 48 consecutive patients referred to our institution with peripheral blood monocytosis. Thirty-six patients fulfilled the WHO criteria for CMML; 12 were diagnosed with reactive monocytosis. Of the patients with CMML, 28 showed pseudonormal growth with or without leukemic cluster growth, another four showed exclusively leukemic growth. None of the patients with reactive monocytosis showed either leukemic or pseudonormal growth. With a specificity of 100% and a sensitivity of 89%, the CFU-C assay has a unique potential to distinguish CMML from reactive monocytosis. 相似文献
105.
Kouriba B Traore HA Dabo A Sangare L Guindo H Keita AS Reimert CM van Dam GJ Deelder AM Doumbo O Dessein AJ 《The Journal of infectious diseases》2005,192(12):2152-2159
BACKGROUND: Schistosoma haematobium infection causes severe urinary disease and considerable mortality. The factors that determine disease progression from mild to severe stages are not fully understood. METHODS: Here we describe a cross-sectional epidemiological study of kidney and bladder diseases in 2 Dogon populations with different exposure to S. haematobium infection. RESULTS: Early and high exposure resulted in more-severe disease, especially among young subjects, without clear evidence of a more-rapid development of immunity. Nevertheless, 50%-60% of subjects of all age classes in both villages showed no evidence of disease. Kidney and bladder disease peaked biphasically among young subjects and adults >25 years old. The first peak corresponded with infections of maximum intensity, whereas the second peak occurred among adults with infections of very low intensity. Kidney disease was correlated with circulating anodic antigen concentration in serum, whereas bladder disease was correlated with egg count and eosinophil cationic protein concentration in urine. Kidney and bladder disease did not correlate. Severe kidney disease was more frequent in certain families. CONCLUSIONS: The frequency of urinary disease is increased by infections acquired early during life, is regulated by strong clinical immunity in certain subjects, and may be dependent on hereditary factors. Kidney and bladder disease may involve different mechanisms of pathogenesis, which may differ between children and adults. 相似文献
106.
107.
Anemia in Children With Cancer Is Associated With Decreased Erythropoietic Activity and Not With Inadequate Erythropoietin Production 总被引:4,自引:4,他引:4
108.
Dhillon KS Cohan P Darwin C Van Herle A Chopra IJ 《Metabolism: clinical and experimental》2004,53(9):1101-1106
Elevation of serum parathyroid hormone (PTH) level in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism has been described in up to 40% of patients, but little is known about its etiology or clinical significance. To better understand the cause of this phenomenon, we studied 49 patients without renal dysfunction or osteomalacia who underwent parathyroidectomy for primary hyperparathyroidism. Patients were categorized into 2 groups based on their serum PTH and calcium levels after parathyroidectomy: (1) elevated PTH with eucalcemia (n = 21), (2) normal PTH with eucalcemia (n = 28). Elevation of serum PTH with eucalcemia after parathyroidectomy occurred in 43% of patients. Patients in group 1 had significantly higher preoperative and postoperative mean serum PTH levels and significantly lower postoperative serum levels of 1,25(OH)(2)D(3), 1,25(OH)(2)D(3)/25(OH)D(3) ratio, and 1,25(OH)(2)D(3)/PTH ratio compared with patients in group 2. Serum PTH in group 1 patients normalized as early as 3 months, but remained elevated in some patients for more than 4 years, and was not associated with development of recurrent hypercalcemia. Normalization of serum PTH in group 1 patients was associated with significant increase in 1,25(OH)(2)D(3) and 1,25(OH)(2)D(3)/PTH ratio. Our data suggest that elevation of serum PTH in eucalcemic patients after parathyroidectomy is a frequently reversible state of resistance of the kidneys to PTH-mediated 1-alpha hydroxylation of 25(OH)D(3) and does not signify subsequent recurrence of hyperparathyroidism. 相似文献
109.
Stephan B Danik Moussa Mansour Jagmeet Singh Vivek Y Reddy Patrick T Ellinor David Milan E Kevin Heist Andre d'Avila Jeremy N Ruskin Theofanie Mela 《Heart rhythm》2007,4(4):439-442
BACKGROUND: The rapid evolution of implantable cardioverter-defibrillator (ICD) leads has resulted in thinner active fixation leads. While these advances have made the leads more versatile, new configurations may be associated with unforeseen complications. OBJECTIVE: The purpose of this study was to determine the incidence of perforation and dislodgement of defibrillator leads in a single center in the year 2005. METHODS: All patients who underwent percutaneous ICD implantation at the Massachusetts General Hospital using an endocardial right ventricular lead were included in this study. The specific leads analyzed were the Riata (1580/1581 and 1590/1591, St. Jude Medical, St Paul, Minnesota, USA;) and Sprint Fidelis (6949-65, Medtronic, Minneapolis, Minnesota, USA.). Information was collected retrospectively. RESULTS: A total of 130 Riata leads and 111 Sprint Fidelis leads were implanted at the Massachusetts General Hospital during this time period. A total of five lead perforations occurred in patients implanted with the Riata lead as compared with none with the Sprint Fidelis lead (3.8% vs. 0%, respectively; P <.05). Two of the five patients with perforation required pericardiocentesis for tamponade. Clinical symptoms of perforation developed 1-10 days after implant. Moreover, there were five additional lead revisions in the Riata group, which were likely due to dislodgement and/or microperforation, as compared with none in the Sprint Fidelis group (7.7% vs. 0%, respectively; P <.005). CONCLUSIONS: In 2005, at one institution, there were significantly more cardiac perforations and lead revisions with the Riata lead as compared with the Sprint Fidelis right ventricular defibrillator lead. Further data are required to determine whether certain lead characteristics are responsible for this observation. 相似文献
110.
E. Kevin Heist Jianping Chevalier Godtfred Holmvang Jagmeet P. Singh Patrick T. Ellinor David J. Milan Andre D’Avila Theofanie Mela Jeremy N. Ruskin Moussa Mansour 《Journal of interventional cardiac electrophysiology》2006,17(1):21-27
Objective Integration of 3-D electroanatomic mapping with Computed Tomographic (CT) and Magnetic Resonance (MR) imaging is gaining acceptance
to facilitate catheter ablation of atrial fibrillation. This is critically dependent on accurate integration of electroanatomic
maps with CT or MR images. We sought to examine the effect of patient- and technique-related factors on integration accuracy
of electroanatomic mapping with CT and MR imaging of the left atrium.
Materials and methods Sixty-one patients undergoing catheter-based atrial fibrillation (AF) ablation procedures were included. All patients underwent
cardiac CT (n = 11) or MR (n = 50) imaging, and image integration with real-time electroanatomic mapping of the aorta and left atrium (LA). CARTO-Merge
software (Biosense-Webster) was used to calculate the overall average accuracy of integration of electroanatomic points with
the CT and MR-derived reconstructions of the LA and aorta.
Results There was a significant correlation between LA size assessed by electroanatomic mapping (112 ± 31 ml) and average integration
error (1.9 ± 0.6 mm) (r = 0.46, p = 0.0003). There was also greater integration error for patients with LA volume ≥ 110 ml (n = 31) versus < 110 ml (n = 30) (p = 0.004). In contrast, there was no significant association between average integration error and paroxysmal versus persistent
AF, left ventricular ejection fraction, days from imaging to electroanatomic mapping, or images derived from CT versus MR.
Conclusions Patients with larger LA volume may be prone to greater error during integration of electroanatomic mapping with CT and MR
imaging. Strategies to reduce integration error may therefore be especially useful in patients with large LA volume. 相似文献